Press Release: Fresenius : Breakthrough Study Demonstrates that High-Dose Hemodiafiltration Treatment for Kidney Failure Patients Significantly Reduces Mortality Rates

The CONVINCE Trial study compares high-dose hemodiafiltration with standard, high-flux hemodialysis Study revealed a 23% decrease in mortality rates for patients treated with high-volume hemodiafiltration compared to those treated with more commonly used high-flux hemodialysis Exploration...